| ATPC 0.1253 79.00% | MTEN 0.0327 -7.37% | OCG 0.01 -15.25% | SOXS 2.08 -8.77% | AUID 2.035 105.04% | IVP 0.0515 -37.20% | CJMB 3.5694 218.70% | ZSL 3.045 8.17% | SLV 81.5 -3.62% | NVDA 188.1886 2.76% | APLT 0.1018 1.90% | SPHL 8.9182 296.36% | INTC 48.34 -0.78% | BNKK 4.6418 66.97% | SOXL 60.565 9.36% | TQQQ 55.5586 3.21% | DVLT 0.7554 5.18% | ASST 0.9847 -4.40% | BYND 1.02 6.04% | TSLL 18.48 2.27% | SIDU 3.675 -2.00% | EEM 58.15 0.69% | JTAI 0.4798 5.54% | AMD 236.8512 5.93% | TZA 5.985 -2.84% | TSLS 5.125 -1.25% | ONDS 13.065 -3.65% | MSTX 4.745 -8.75% | PTHL 0.4676 6.32% | NOK 6.6459 4.50% | PCLA 0.2119 -4.12% | TSM 346.17 5.83% | IBRX 3.3386 10.55% | SEGG 1.0804 16.59% | RZLV 4.653 14.61% | VALE 14.675 0.44% | SPY 694.59998 0.61% | GRAB 4.48 -3.24% | IBIT 54.3599 -1.95% | QQQ 626.23 1.08% | BBAI 6.285 0.40% | SQQQ 64.8096 -3.18% | GPUS 0.3055 -4.80% | OCUL 11.05 -0.18% | XLF 54.63 0.89% | CRWV 97.83 8.94% | DUST 5.795 -0.09% | TSLA 444.3829 1.18% | BMNR 31.59 -3.26% | EVTV 3.5233 13.65%

Understanding Market Valuations: A Comparative Analysis

Chicago Atlantic BDC, Inc. (NASDAQ:LIEN) is showing promising growth potential. LIEN is trading at $10.10, but its discounted cash flow (DCF) valuation is $14.35. This results in a price percentage difference of 42.03%, suggesting a positive outlook and potential for price appreciation. LIEN's strong position among its peers highlights its growth prospects.

Cinemark Holdings, Inc. (NYSE:CNK) is another peer, trading at $30.64 with a DCF of $18.05. This results in a price percentage difference of -41.08%, indicating a less favorable outlook compared to its current market price. Despite being a well-known name in the entertainment industry, CNK faces challenges in aligning its market price with its valuation.

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) trades at $0.389 with a DCF of $0.3556, showing a price percentage difference of -8.57%. This smaller discrepancy suggests a closer alignment between its market price and valuation, though it still indicates a slightly negative outlook. VRPX's focus on pharmaceutical developments may influence its market performance.

Regis Corporation (NYSE:RGS) is trading at $22.65, but its DCF is only $1.95, resulting in a significant price percentage difference of -91.37%. This large gap suggests a highly pessimistic view from analysts, similar to RGC. RGS's market challenges are evident in its substantial discrepancy between market price and valuation.

Published on: July 5, 2025